Grand Pharmaceutical Group Limited
HKEX:0512.HK
4.6 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10,529.59 | 9,562.285 | 8,597.975 | 6,352.919 | 6,590.635 | 5,958.355 | 4,770.85 | 3,696.164 | 3,245.546 | 3,122.116 | 2,658.282 | 2,059.307 | 1,647.576 | 1,054.754 | 545.435 | 269.882 | 49.045 | 42.408 | 46.384 | 63.162 |
| Cost of Revenue
| 4,005.524 | 3,610.806 | 3,350.737 | 2,317.725 | 2,557.575 | 2,796.841 | 2,291.353 | 1,963.736 | 1,895.062 | 1,928.469 | 1,771.752 | 1,414.124 | 1,132.477 | 679.947 | 295.341 | 160.136 | 26.391 | 23.438 | 26.296 | 42.597 |
| Gross Profit
| 6,524.066 | 5,951.479 | 5,247.238 | 4,035.194 | 4,033.06 | 3,161.514 | 2,479.497 | 1,732.428 | 1,350.484 | 1,193.647 | 886.53 | 645.183 | 515.099 | 374.807 | 250.094 | 109.746 | 22.654 | 18.97 | 20.088 | 20.565 |
| Gross Profit Ratio
| 0.62 | 0.622 | 0.61 | 0.635 | 0.612 | 0.531 | 0.52 | 0.469 | 0.416 | 0.382 | 0.333 | 0.313 | 0.313 | 0.355 | 0.459 | 0.407 | 0.462 | 0.447 | 0.433 | 0.326 |
| Reseach & Development Expenses
| 571.985 | 531.924 | 331.421 | 219.31 | 186.13 | 137.49 | 84.713 | 65.199 | 106.898 | 81.833 | 62.693 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,234.377 | 870.032 | 909.617 | 685.239 | 609.621 | 552.506 | 541.256 | 420.786 | 428.948 | 372.436 | 315.536 | 236.986 | 205.911 | 121.967 | 89.722 | 56.234 | 48.285 | 34.957 | 49.609 | 54.669 |
| Selling & Marketing Expenses
| 2,567.628 | 2,306.519 | 2,397.848 | 1,860.086 | 2,239.494 | 1,759.869 | 1,325.289 | 902.724 | 641.662 | 608.155 | 456.608 | 340.313 | 261.906 | 207.939 | 114.458 | 61.059 | 26.347 | 0 | 0 | 0 |
| SG&A
| 3,288.684 | 2,901.931 | 2,897.238 | 2,306.612 | 2,680.71 | 2,312.375 | 1,866.545 | 1,323.51 | 1,070.61 | 980.591 | 772.144 | 577.299 | 467.817 | 329.906 | 204.18 | 117.293 | 74.632 | 34.957 | 49.609 | 54.669 |
| Other Expenses
| 35.277 | 40.247 | 46.159 | 41.079 | 38.365 | 38.665 | 55.618 | 4.609 | 5.423 | 3.178 | 3.719 | 5.743 | -78.083 | 21.631 | 17.244 | -8.656 | -4.456 | -5.408 | -6.519 | -11.13 |
| Operating Expenses
| 3,860.669 | 3,433.855 | 3,228.659 | 2,525.922 | 2,866.84 | 2,089.188 | 1,749.758 | 1,249.357 | 981.75 | 892.059 | 690.671 | 505.742 | 389.734 | 189.461 | 196.888 | 108.637 | 70.176 | 40.352 | 134.972 | 177.075 |
| Operating Income
| 2,663.397 | 2,517.624 | 2,018.579 | 1,509.272 | 1,166.22 | 892.306 | 665.872 | 457.741 | 357.015 | 300.083 | 189.478 | 157.321 | 125.869 | 185.346 | 53.206 | 6.623 | 47.522 | 6.778 | 102.285 | 145.374 |
| Operating Income Ratio
| 0.253 | 0.263 | 0.235 | 0.238 | 0.177 | 0.15 | 0.14 | 0.124 | 0.11 | 0.096 | 0.071 | 0.076 | 0.076 | 0.176 | 0.098 | 0.025 | 0.969 | 0.16 | 2.205 | 2.302 |
| Total Other Income Expenses Net
| -294.192 | 43.055 | 653.391 | 502.332 | 74.791 | -8.407 | -106.933 | -143.777 | -116.452 | -97.162 | -57.198 | -41.786 | -26.405 | -27.18 | -26.847 | -16.064 | -8.568 | 9.196 | 6.08 | 0.006 |
| Income Before Tax
| 2,369.205 | 2,560.679 | 2,671.97 | 2,011.604 | 1,241.011 | 883.899 | 558.939 | 313.964 | 240.563 | 202.921 | 132.28 | 115.535 | 99.464 | 158.166 | 48.786 | -22.687 | -56.09 | -12.186 | -108.804 | -156.504 |
| Income Before Tax Ratio
| 0.225 | 0.268 | 0.311 | 0.317 | 0.188 | 0.148 | 0.117 | 0.085 | 0.074 | 0.065 | 0.05 | 0.056 | 0.06 | 0.15 | 0.089 | -0.084 | -1.144 | -0.287 | -2.346 | -2.478 |
| Income Tax Expense
| 448.755 | 418.642 | 380.8 | 292.374 | 230.485 | 147.46 | 73.181 | 44.602 | 40.156 | 27.198 | 26.994 | 10.83 | 12.793 | 3.889 | 6.873 | -0.004 | -2.205 | -0.245 | -6.08 | -0.006 |
| Net Income
| 1,879.998 | 2,079.419 | 2,402.563 | 1,792.661 | 1,150.948 | 712.667 | 460.811 | 269.143 | 180.906 | 175.208 | 99.658 | 67.305 | 54.235 | 97.973 | 28.344 | -24.233 | -52.03 | -11.941 | -108.804 | -156.504 |
| Net Income Ratio
| 0.179 | 0.217 | 0.279 | 0.282 | 0.175 | 0.12 | 0.097 | 0.073 | 0.056 | 0.056 | 0.037 | 0.033 | 0.033 | 0.093 | 0.052 | -0.09 | -1.061 | -0.282 | -2.346 | -2.478 |
| EPS
| 0.54 | 0.59 | 0.68 | 0.52 | 0.35 | 0.27 | 0.21 | 0.13 | 0.092 | 0.089 | 0.051 | 0.034 | 0.028 | 0.066 | 0.025 | -0.019 | -0.046 | -0.011 | -0.11 | -0.75 |
| EPS Diluted
| 0.54 | 0.59 | 0.68 | 0.52 | 0.34 | 0.26 | 0.19 | 0.12 | 0.089 | 0.089 | 0.051 | 0.034 | 0.028 | 0.066 | 0.023 | -0.019 | -0.046 | -0.011 | -0.11 | -0.75 |
| EBITDA
| 3,055.607 | 2,912.536 | 2,358.098 | 1,796.333 | 1,643.356 | 1,128.621 | 909.135 | 677.169 | 548.393 | 471.317 | 286.349 | 234.438 | 171.884 | 245.812 | 92.248 | 6.011 | -36.789 | -11.072 | -91.155 | -114.194 |
| EBITDA Ratio
| 0.29 | 0.305 | 0.274 | 0.283 | 0.249 | 0.189 | 0.191 | 0.183 | 0.169 | 0.151 | 0.108 | 0.114 | 0.104 | 0.233 | 0.169 | 0.022 | -0.75 | -0.261 | -1.965 | -1.808 |